IL170350A - Method for preparing polymorphism of irinotecan hydrochloride - Google Patents
Method for preparing polymorphism of irinotecan hydrochlorideInfo
- Publication number
- IL170350A IL170350A IL170350A IL17035005A IL170350A IL 170350 A IL170350 A IL 170350A IL 170350 A IL170350 A IL 170350A IL 17035005 A IL17035005 A IL 17035005A IL 170350 A IL170350 A IL 170350A
- Authority
- IL
- Israel
- Prior art keywords
- polymorphism
- preparing
- irinotecan hydrochloride
- irinotecan
- hydrochloride
- Prior art date
Links
- 229960000779 irinotecan hydrochloride Drugs 0.000 title 1
- GURKHSYORGJETM-WAQYZQTGSA-N irinotecan hydrochloride (anhydrous) Chemical compound Cl.C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 GURKHSYORGJETM-WAQYZQTGSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003046908 | 2003-02-25 | ||
| PCT/JP2004/002126 WO2004076460A1 (ja) | 2003-02-25 | 2004-02-24 | イリノテカン塩酸塩の結晶多形の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL170350A true IL170350A (en) | 2010-11-30 |
Family
ID=32923248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL170350A IL170350A (en) | 2003-02-25 | 2005-08-18 | Method for preparing polymorphism of irinotecan hydrochloride |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7488825B2 (Direct) |
| EP (1) | EP1598356A4 (Direct) |
| JP (1) | JP4566128B2 (Direct) |
| KR (1) | KR101095382B1 (Direct) |
| CN (1) | CN100418970C (Direct) |
| AU (1) | AU2004215560B2 (Direct) |
| BR (1) | BRPI0407791A (Direct) |
| CA (1) | CA2516643C (Direct) |
| IL (1) | IL170350A (Direct) |
| NZ (1) | NZ541990A (Direct) |
| TW (1) | TW200508239A (Direct) |
| WO (1) | WO2004076460A1 (Direct) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060046993A1 (en) * | 2004-09-01 | 2006-03-02 | Pharmacia Italia S.P.A. | Crystalline polymorphic form of irinotecan hydrochloride |
| JP4829120B2 (ja) * | 2004-10-01 | 2011-12-07 | 株式会社ヤクルト本社 | イリノテカン酸付加塩 |
| AU2006292328B2 (en) | 2005-09-20 | 2012-12-20 | Scinopharm Singapore Pte, Ltd. | Novel crystal forms of irinotecan hydrochloride |
| CN101318964B (zh) * | 2007-06-07 | 2010-12-15 | 上海迪赛诺医药发展有限公司 | 盐酸伊立替康新晶型及其制备方法 |
| US7572803B2 (en) * | 2007-10-25 | 2009-08-11 | The Christus Stehlin Foundation For Cancer Research | Hydrated crystalline esters of camptothecin |
| IT1391757B1 (it) * | 2008-11-11 | 2012-01-27 | Antibioticos Spa | Irinotecan cloridrato cristallino e metodi per la sua preparazione |
| CN102311443B (zh) * | 2011-08-24 | 2014-07-16 | 上海北卡医药技术有限公司 | 盐酸伊立替康的新晶型及其制备方法 |
| CN102617584B (zh) * | 2012-03-14 | 2013-10-16 | 海南锦瑞制药股份有限公司 | 一种盐酸伊立替康化合物及其药物组合物 |
| US10919905B2 (en) * | 2019-05-16 | 2021-02-16 | Scinopharm Taiwan, Ltd. | Polymorphism for irinotecan free base |
| CN111100135A (zh) * | 2019-10-24 | 2020-05-05 | 连云港杰瑞药业有限公司 | 一种盐酸伊立替康的精制方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6247193A (ja) | 1985-08-26 | 1987-02-28 | 内橋エステック株式会社 | 電子部品のはんだ付方法 |
| JPH034077A (ja) | 1989-05-30 | 1991-01-10 | Nissho Corp | 逆止弁 |
| JPH07277981A (ja) | 1994-04-12 | 1995-10-24 | Yakult Honsha Co Ltd | 徐放性抗腫瘍製剤 |
| JPH1017472A (ja) | 1996-07-04 | 1998-01-20 | Yakult Honsha Co Ltd | 徐放性抗腫瘍製剤 |
| PL372318A1 (en) * | 2002-03-01 | 2005-07-11 | Pharmacia Italia S.P.A. | Crystalline polymorphic form of irinotecan hydrochloride |
-
2004
- 2004-02-24 AU AU2004215560A patent/AU2004215560B2/en not_active Ceased
- 2004-02-24 NZ NZ541990A patent/NZ541990A/en not_active IP Right Cessation
- 2004-02-24 WO PCT/JP2004/002126 patent/WO2004076460A1/ja not_active Ceased
- 2004-02-24 EP EP04714012A patent/EP1598356A4/en not_active Withdrawn
- 2004-02-24 US US10/546,687 patent/US7488825B2/en not_active Expired - Fee Related
- 2004-02-24 KR KR1020057014560A patent/KR101095382B1/ko not_active Expired - Fee Related
- 2004-02-24 CA CA2516643A patent/CA2516643C/en not_active Expired - Fee Related
- 2004-02-24 CN CNB2004800047816A patent/CN100418970C/zh not_active Expired - Fee Related
- 2004-02-24 BR BRPI0407791-1A patent/BRPI0407791A/pt not_active IP Right Cessation
- 2004-02-24 JP JP2005502882A patent/JP4566128B2/ja not_active Expired - Fee Related
- 2004-02-25 TW TW093104774A patent/TW200508239A/zh not_active IP Right Cessation
-
2005
- 2005-08-18 IL IL170350A patent/IL170350A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2516643C (en) | 2011-04-19 |
| JP4566128B2 (ja) | 2010-10-20 |
| BRPI0407791A (pt) | 2006-02-14 |
| CA2516643A1 (en) | 2004-09-10 |
| WO2004076460A1 (ja) | 2004-09-10 |
| US7488825B2 (en) | 2009-02-10 |
| KR101095382B1 (ko) | 2011-12-16 |
| TWI326684B (Direct) | 2010-07-01 |
| CN100418970C (zh) | 2008-09-17 |
| NZ541990A (en) | 2009-04-30 |
| TW200508239A (en) | 2005-03-01 |
| EP1598356A4 (en) | 2008-07-02 |
| AU2004215560A1 (en) | 2004-09-10 |
| JPWO2004076460A1 (ja) | 2006-06-01 |
| US20060234904A1 (en) | 2006-10-19 |
| AU2004215560B2 (en) | 2009-09-24 |
| KR20050100661A (ko) | 2005-10-19 |
| CN1751048A (zh) | 2006-03-22 |
| EP1598356A1 (en) | 2005-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL183091A0 (en) | Method for preparing n-phenylpyrazole-1-carboxyamides | |
| IL163820A0 (en) | Crystalline polymorphic form of irinotecan hydrochloride | |
| AU2003250196A8 (en) | Method for preparing oligonucleotides | |
| SG137677A1 (en) | Improved process for preparing polyalkenylsuccinimides | |
| IL158016A (en) | Method for preparing decorative elements | |
| IL170887A (en) | Process for the preparation of 2 - cyanopyrolidines converted at position n | |
| EP1732394A4 (en) | DEHYDRATION-GRIDING PROCESS | |
| GB0410533D0 (en) | Method for identification of nucleation | |
| ZA200703495B (en) | Process for the preparation of irbesartan hydrochloride | |
| IL177039A0 (en) | Improved process for preparing rebamipide | |
| PL377822A1 (pl) | Sposób sporządzania octanu metylo-2-difenylometylosulfinylu | |
| PL2181982T3 (pl) | Sposób wytwarzania chlorowodorku wenlafaksyny w formie I | |
| GB0401475D0 (en) | Method of signalling | |
| IL178069A0 (en) | Process for preparing n-aryl-piperazine derivatives | |
| PL1928883T3 (pl) | Sposób otrzymywania chlorowodorku irynotekanu | |
| EP2147916A4 (en) | PROCESS FOR THE PREPARATION OF SYNTHETIC TAXANES | |
| PL376796A1 (pl) | Sposób wytwarzania inhibitorów fosfodiesterazy-4 | |
| GB2415696B (en) | Process for preparing amlodipine mesylate monohydrate | |
| PL1654240T3 (pl) | Sposób otrzymywania N-arylomorfolinonów | |
| AM1402A2 (en) | Hardtack preparing method | |
| GB2412373B (en) | Process for preparing guggulsterones | |
| SI1487840T1 (sl) | Kristalinična polimorfna oblika irinotekan hidroklorida | |
| GEU20041064U (en) | Method for production of Matsoni | |
| ZA200803269B (en) | Polymorphic form of lercanipine hydrochloride and process for the preparation thereof | |
| PL376832A1 (pl) | Sposób wytwarzania polimorficznej postaci chlorowodorku sertraliny |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |